Partner Content Partner Content Final Reminder: 1 Week Until SMi’s Lyophilization USA 1 Week Until Lyophilization USA
Partner Content Partner Content Hot Sessions You Cannot Afford to Miss at SMi’s Lyophilizati... 3 Weeks to go for #LYOUSA
Partner Content Partner Content Only 4 weeks remain until SMi’s 3rd annual Lyophilization US... Lyophilization USA - Updates - 4 Weeks Remaining
Partner Content Partner Content Spotlight on Key Sessions at SMi’s 3rd Annual Lyophilization... Hear from Industry Experts on Key Sessions
Partner Content Partner Content Updates in Cutting Edge Lyophilization Technology Latest Updated for Lyophilization USA
News Roche places a $1bn bet on C4T degrader-antibody conjugates Roche is paying $20 million upfront to secure rights to two degrader-antibody conjugates (DACs) for cancer developed by longtime partner C4T.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
